It is my pleasure to write to you on the occasion of the 10th Anniversary of NeuroTrax. When we first developed the MindStreams concept, nobody was thinking about computerized, office-based neuropsychological testing. Today MindStreams is a household word among neurologists, neuropsychologists and other professionals involved in cognitive care. Over 70,000 MindStreams tests have been run in clinical and research practices. Clinical validity and usability have been established in over 45 peer-reviewed articles based on independent academic research.

My purpose here is to provide an update on the many clinical uses for MindStreams testing, as supported by the research and experience of expert MindStreams users. Most professionals start using MindStreams based on one clinical indication and are not aware of other ways that it can enhance their patient care.

MindStreams testing is used by qualified neurocognitive experts for measuring cognitive function to aid clinicians in documenting cognitive health or cognitive impairment for the following indications:

• Cognitive health evaluation – To help establish the profile of cognitive strengths and weaknesses at baseline and following new symptoms.
  
  
• Memory complaints in the elderly – To provide evidence of objective cognitive decline, as required by the accepted diagnostic criteria of MCI or dementia.
  
  
• “Worried Well” – To provide objective evidence of cognitive performance appropriate for age and education, and therefore allay anxiety regarding cognitive disease.
  
  
• Track effects of treatment – To provide quantitative follow-up of treatment for dementia or other cognitive disease.
  
  
• Traumatic brain injury following car accidents – To provide objective evidence of areas of cognitive impairment; to relate the changes to the patient’s complaints.
  
  
• Sports concussion – To provide objective evidence of changes in cognitive impairment relative to baseline, to help the clinician in determining fitness for return to sports.
  
  
• Sleep disorders – To establish the cognitive baseline function before treatment and to provide quantitative follow-up following treatment for sleep disorders.
  
  
• Attention Deficit Disorder, Adult – To provide objective evidence of cognitive
  impairment in executive function and attention, as well as other domains that may be affected in ADD/ADHD and its comorbidities.
  
  
• Attention Deficit Hyperactivity Disorder, Child – To provide objective evidence of cognitive impairment in executive function and attention, as well as other domains that may be affected in ADD/ADHD and its comorbidities. May help determine reasons for learning difficulties, as well.
  
  
• Multiple sclerosis – To provide objective evidence of cognitive decline that may be attributable to the patient’s known condition of MS.
  
  
• Other neurological and psychiatric indications – To provide objective evidence of cognitive decline that may be attributable to the patient’s known condition:
• Parkinson’s disease
• Epilepsy
• Drug side effects
• Depression
• Schizophrenia
  
  

As you know good, clinical care demands attention to detail and a high level of expertise in the interpretation of MindStreams cognitive assessment results. We are dedicated to working with the growing community of cognitively-minded health care professionals to improve education and awareness of state-of-the-art cognitive evaluation. We also highly recommend and can assist in referral of cognitive testing data to neuropsychologists and other qualified experts for clinical interpretation.

As always, I am happy to hear from you and sincerely interested in your feedback and ideas.

Best regards,

Ely Simon, MD
CEO and Founder, NeuroTrax Corporation